Breast Biopsy Devices Market is steadily progressing, with a 5.5% CAGR driving it towards US$ 3.6 Billion by 2032 | FMI

The Breast Biopsy Devices Market refers to the industry involved in the manufacturing and distribution of devices used for performing breast biopsies. A breast biopsy is a medical procedure in which a sample of breast tissue is removed and examined to determine if it is cancerous or benign.

Breast biopsy devices are designed to assist healthcare professionals in accurately and safely obtaining tissue samples from the breast. These devices are typically used when a suspicious lump or abnormality is detected during a mammogram or clinical examination. They help in diagnosing breast cancer and determining the appropriate course of treatment.

Get your PDF Sample Report with Latest Market Information! https://www.futuremarketinsights.com/reports/sample/rep-gb-1496

The global demand for breast biopsy devices is expected to grow at a CAGR of about 5.5% from 2022 to 2032, to be valued US$ 3.6 Billion, with a market valuation of around US$ 2.1 billion in 2022. According to Future Market Insights, the biopsy needle segment as a product will account for approximately 23.4% of the global market in 2021.

The Key Takeaways Regarding The Breast Biopsy Devices Market Are As Follows:

• Market Growth: The breast biopsy devices market has been experiencing significant growth due to increasing awareness about breast cancer, advancements in diagnostic technologies, and rising incidence of breast cancer worldwide.
• Rising Incidence of Breast Cancer: Breast cancer is one of the most commonly diagnosed cancers in women globally. The increasing prevalence of breast cancer has led to a growing demand for breast biopsy devices for early detection and accurate diagnosis.
• Technological Advancements: The market has witnessed technological advancements in breast biopsy devices, such as the introduction of minimally invasive techniques like vacuum-assisted biopsy (VAB) and core needle biopsy (CNB). These techniques offer advantages like reduced invasiveness, shorter procedure time, and minimal scarring.
• Increasing Adoption of Stereotactic Biopsy: Stereotactic biopsy, a type of image-guided biopsy, has gained significant popularity due to its accuracy and reliability. This technique allows precise localization of suspicious lesions, resulting in improved diagnostic outcomes.
• Growing Preference for MRI-Guided Biopsy: Magnetic resonance imaging (MRI)-guided biopsy is being increasingly adopted as it offers better visualization of suspicious lesions, especially for patients with dense breast tissue. MRI-guided biopsy provides accurate targeting and sampling of lesions, contributing to improved diagnostic accuracy.

Breast Biopsy Devices Market: Competition Analysis

The FMI’s study presents a comprehensive analysis of global, regional, and country-level players active in the Breast Biopsy Devices market. Competitive information detailed in the Breast Biopsy Devices market report has been based on innovative product launches, distribution channels, local networks, industrial penetration, production methods, and revenue generation of each market player. Furthermore, growth strategies and mergers & acquisitions (M&A) activities associated with the players are enclosed in the Breast Biopsy Devices market report.

Elevate Your Understanding With Our Insightful Methodology Now! https://www.futuremarketinsights.com/request-report-methodology/rep-gb-1496

Key players covered in the report include:

• ARGON MEDICAL
• Becton Dickinson and Company
• C.R. Bard, Inc.
• Cook Medical Inc.
• Devicor Medical Products, Inc.
• F. Hoffmann-La Roche Ltd.,
• GE Healthcare
• Hologic, Inc.
• Leica Biosystems
• Medax Srl Unipersonale
• Planmed Oy,
• Scion Medical Technologies, LLC
• Siemens Healthier

Breast Biopsy Devices Market: Segmentation

Valuable information covered in the FMI’s Breast Biopsy Devices market report has been segregated into key segments and sub-segments.

By Product:

• Biopsy Needle
  • Core Needles
  • Fine Aspiration Needles
• MRI-Guide Biopsy Systems
• Ultrasound Guided Breast Biopsy Systems
  • Two-Dimensional (2-D) Mammographic Ultrasonic Scanning Systems
  • Three-Dimensional (3-D) B-Mode Mammographic Ultrasonic Scanning Systems
• Vacuum-Assisted Device (VAD)
• Guide Wire (Localization Wire)
• Breast Biopsy Marker

By Indication:

• Complex cyst
• Solid mass
• Suspicious solid mass( fibroadenoma )
• Suspicious micro calcifications

By End User:

• Hospitals
• Specialty Clinics
• Ambulatory Surgical Centers
• Cancer Research Institutes

For More Information, Query or Customization of this report – Visit! https://www.futuremarketinsights.com/customization-available/rep-gb-1496

About Future Market Insights (FMI)

Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.

Contact Us:        

Nandini Singh Sawlani   

Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube